Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Chronic obstructive pulmonary disease COPD and other airway diseases are often diagnosed using breathing tests like spirometry, which require forceful exhalation and can be uncomfortable or difficult for some patients. This research evaluates newer lung function tests to see if they can diagnose COPD as accurately as standard spirometry, particularly in both hospital and community settings. The study also investigates how practical, affordable, and user-friendly these newer tests are for patients and healthcare systems. Participants will undergo several lung function assessments including capnography combined with machine learning algorithms, oscillometry, fractional exhaled nitric oxide FENO, gas transfer tests, body plethysmography for static lung volumes, and spirometry. These tests will be conducted alongside standard lung function testing in various settings such as community diagnostic centers, secondary care hospitals, lung cancer screening programs, and community events. Some participants may also complete surveys or interviews to share their experiences. Throughout the study, researchers will monitor the accuracy and usability of these tests, measuring outcomes like test failure rates, time taken per test, and ability to detect early or alternative lung conditions. Participants will provide informed consent and be assessed for clinical stability before testing. The study will continue until 2029, with primary outcomes focusing on diagnostic accuracy of capnography combined with machine learning. Patient comfort and practical feasibility across healthcare environments are key areas of assessment.